134.01
Transmedics Group Inc stock is traded at $134.01, with a volume of 574.77K.
It is up +1.95% in the last 24 hours and up +5.42% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$131.45
Open:
$132.1
24h Volume:
574.77K
Relative Volume:
0.56
Market Cap:
$4.77B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
142.56
EPS:
0.94
Net Cash Flow:
$-120.51M
1W Performance:
+5.08%
1M Performance:
+5.42%
6M Performance:
+114.93%
1Y Performance:
-11.03%
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TMDX
Transmedics Group Inc
|
134.01 | 4.77B | 401.09M | 32.64M | -120.51M | 0.94 |
![]()
ABT
Abbott Laboratories
|
136.01 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
107.41 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
395.63 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.21 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
Nov-22-24 | Downgrade | Needham | Buy → Hold |
Oct-29-24 | Reiterated | Needham | Buy |
Oct-29-24 | Reiterated | Oppenheimer | Outperform |
Sep-24-24 | Initiated | Robert W. Baird | Outperform |
Aug-21-24 | Initiated | Needham | Buy |
Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
Jun-04-24 | Initiated | Stephens | Overweight |
Mar-28-24 | Initiated | Piper Sandler | Overweight |
Jul-19-23 | Initiated | Robert W. Baird | Outperform |
Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-07-20 | Initiated | Oppenheimer | Outperform |
May-28-19 | Initiated | Canaccord Genuity | Buy |
May-28-19 | Initiated | Cowen | Outperform |
May-28-19 | Initiated | JP Morgan | Overweight |
May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.9%Should You Sell? - MarketBeat
TransMedics Group Inc (TMDX) Trading Down 8.65% on Jun 18 - GuruFocus
TransMedics (TMDX) Continues to Scale Innovation in Organ Transplant Care - Yahoo Finance
Investors in shares of TransMedics Group, Inc. (NASDAQ:TMDX) Announced by the Shareholders Foundation in Connection with Lawsuit - Newswire :) Press Release Distribution
Boasting A 18% Return On Equity, Is TransMedics Group, Inc. (NASDAQ:TMDX) A Top Quality Stock? - Yahoo Finance
Handelsbanken Fonder AB Decreases Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $150.00 at Oppenheimer - Defense World
TransMedics price target raised to $150 from $130 at Oppenheimer By Investing.com - Investing.com Canada
10 Best Growth Stocks to Buy According to Billionaires - Insider Monkey
TransMedics Group (TMDX) Sees Price Target Boost by Oppenheimer - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
(TMDX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Oppenheimer Adjusts Price Target for TransMedics (TMDX) to $150 - GuruFocus
Oppenheimer Adjusts Price Target for TransMedics (TMDX) to $150 | TMDX Stock News - GuruFocus
Oppenheimer Hikes TransMedics Group Price Target to $150 From $130, Maintains Outperform Rating - MarketScreener
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Handelsbanken Fonder AB Sells 72,000 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Rhumbline Advisers Sells 537 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Bought by GAMMA Investing LLC - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Insider Anil P. Ranganath Sells 686 Shares - MarketBeat
Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May - MarketBeat
Two Sigma Investments LP Purchases Shares of 12,523 TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
TransMedics at Goldman Sachs Conference: Strategic Growth and Challenges By Investing.com - Investing.com Nigeria
TransMedics at Goldman Sachs Conference: Strategic Growth and Challenges - Investing.com
TransMedics Group, Inc. (TMDX): A Bull Case Theory - Insider Monkey
Transcript : TransMedics Group, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - marketscreener.com
3 Medical Technology Stocks Outperforming in 2025 - MarketBeat
TransMedics: Data Points To Strong Second Quarter, But Beware Of The Second Half - Seeking Alpha
GAMMA Investing LLC Boosts Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
12,523 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Acquired by Two Sigma Investments LP - Defense World
Sugar Maple Asset Management LLC Invests $740,000 in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Wellington Management Group LLP Sells 139,337 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Invests $4.13 Million in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Given “Overweight” Rating at Piper Sandler - Defense World
3 High-Growth Stocks Traders Love and Investors Should Watch - The Globe and Mail
Piper Sandler Boosts TransMedics (TMDX) PT to $145, Keeps Overweight Rating - MSN
Nuveen Asset Management LLC Sells 98,195 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group's (TMDX) "Overweight" Rating Reiterated at Piper Sandler - MarketBeat
TransMedics Group (TMDX) Price Target Raised by Piper Sandler | - GuruFocus
Piper Sandler raises TransMedics stock price target to $145 By Investing.com - Investing.com Canada
TransMedics (TMDX) Price Target Increased by Piper Sandler | TMD - GuruFocus
TransMedics (TMDX) Price Target Increased by Piper Sandler | TMDX Stock News - GuruFocus
TransMedics Group, Inc. (NASDAQ:TMDX) Director Edward M. Basile Sells 5,000 Shares - MarketBeat
TransMedics Group Inc (TMDX) Shares Up 4.58% on Jun 3 - GuruFocus
TransMedics at 45th Annual William Blair: Transforming Organ Transplants - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
4 Analysts Have This To Say About TransMedics Group - Nasdaq
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transmedics Group Inc Stock (TMDX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Basile Edward M | Director |
May 27 '25 |
Option Exercise |
0.70 |
5,000 |
3,500 |
7,866 |
Basile Edward M | Director |
May 27 '25 |
Sale |
126.45 |
5,000 |
632,250 |
2,866 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):